Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

Tower Resources confident of future gains amid farm-out approvals and rising oil prices

Market News
02 Jun 2026
Proactive Investors
View Source
Bullish
pluang ai news

Tower Resources remains optimistic about future benefits as it awaits approvals for farm-outs in Cameroon and Namibia, which are crucial for funding its operations. The company reported a wider annual loss due to a non-cash impairment on its South African licence but noted a positive start to 2026 with rising oil prices. Tower needs to complete farm-out deals with Prime Global Energies and possibly raise more funds soon to support its Cameroon drilling program. A Q4 2026 drilling start is possible, depending on timely approvals.

More News

SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.

SpaceX prioritizes growth over profits, following Amazon's strategy to build future value.

SpaceX is choosing to focus on long-term growth rather than immediate profitability, similar to Amazon's approach in its early years. Experts say SpaceX could be profitable now if it reduced spending on projects like Starship and AI infrastructure, b...

Market News
Bullish
26 minutes ago
Cornerstone expands free sustainability data with updated EPA GHG Emission Factors Hub for scopes 1, 2, and 3 emissions.

Cornerstone expands free sustainability data with updated EPA GHG Emission Factors Hub for scopes 1, 2, and 3 emissions.

Cornerstone has released an updated version of the EPA's GHG Emission Factors Hub, providing free, consolidated data for scopes 1, 2, and 3 greenhouse gas emissions. This update includes new factors for air travel, refrigerants, and aligns with the l...

Others
Bullish
1 hour ago
New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.

New data show Lyell's ronde-cel CAR T-cell therapy is safe and effective for large B-cell lymphoma.

Lyell Immunopharma presented updated safety and translational data for its CAR T-cell therapy, ronde-cel, in treating relapsed or refractory large B-cell lymphoma (LBCL). Over 100 patients treated showed no severe cytokine release syndrome (CRS) and ...

Market News
Bullish
1 hour ago
Ascendis Pharma's TransCon PTH shows 5-year success in hypoparathyroidism treatment, boosting stock.

Ascendis Pharma's TransCon PTH shows 5-year success in hypoparathyroidism treatment, boosting stock.

Ascendis Pharma reported positive five-year results from its Phase 2 PaTH Forward trial of TransCon PTH (palopegteriparatide) for adult hypoparathyroidism. The therapy maintained stable calcium levels, kidney and bone health, and quality of life, all...

Company Fundamentals
Bullish
1 hour ago
SpaceX shares debut at $150, rising to $165, valuing the company near $2 trillion.

SpaceX shares debut at $150, rising to $165, valuing the company near $2 trillion.

SpaceX began trading on the stock market at $150 per share, above its IPO price of $135, marking the largest public offering in history and valuing the company at about $1.96 trillion. The shares quickly rose to $165, reflecting strong demand that ex...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App